Call for Presentations - 2019 International Conference on Opoioids

Deadline December 1, 2018
The International Conference On Opioids (ICOO 2019) Program Committee invites the submission of proposals for Presentations, Posters, Workshops and Corporate Satellite Symposia to be presented during the eighth annual International Conference On Opioids. 

The Future of Opioids: Pain Management and the Public Health 
June 9-11, 2019 in Boston, Massachusetts at the Joseph B. Martin Conference Center at Harvard Medical School. 
   Expanding on the success of our past conferences, this unique forum will be comprised of renowned specialists in all aspects of opioids. This includes the latest advances in basic science, neurology, clinical application, pharmacology, pharmacogenetics, public health, opioid addiction, ethics, legal, regulatory and compliance. The program is designed to enlighten healthcare providers with new data, essential information, and best practices every medical professional needs to know when managing patients on opioid analgesics. 

   The ICOO 2019 Program Committee requests proposals representing all areas of opioid research, treatment, ethics, opioid abuse and addiction. Proposals from individuals and panels will be considered. Multidisciplinary panels are encouraged to include perspectives from physicians, nurses, psychologists, basic scientists, pharmacists, etc. Moderators should seek participation from a varied group of faculty with a maximum of four participants per proposal. Proposals that include both basic and clinical science are encouraged. 
Download a ICOO 2019 Submission Form here. 
Click on the "more" button to the right for details.
Posted: 2018-11-29 More...

All JOM archives now online!


All Journal of Opioid Management back issue archives are now available on this system.

Posted: 2018-02-01 More...
1 - 2 of 2 Items
This site uses cookies to maintain session information critical to the user's experience and environment on this system. Click "Accept Cookies" to continue.
For more details please visit our privacy statement at: Privacy & GDPR